Table 1.

Demographics of patients, acquisition parameters, respiratory support and clinical indications

Subject number	Age (years)	Gender	Slice thickness (mm)	FOV (cm)	Matrix size	Temporal resolution (s)	Respiratory support*	Clinical indication
1	6.9	M	2.4	38×30	320×180×80	8.6	LMA	Metastatic neuroblastoma
2	6.3	F	2.0	32×26	320×180×80	8.8	NC	Tuberous sclerosis
3	4.1	M	2.4	30×24	320×180×66	7.9	ETT	Hepatoblastoma
4	3.7	M	2.4	38×30	320×180×80	8.6	ETT	B- Thalassemia
5	6.0	F	2.4	32×26	320×180×64	7.6	None	Vaginal rhabdomyosarcoma
6	3.8	M	2.4	32×26	320×180×68	7.7	LMA	Hepatoblastoma
7	0.5	F	2.0	26×18	320×156×60	7.0	ETT	Patent ductus arteriosus
8	2.8	M	2.4	30×21	320×156×56	6.1	NC	Neuroblastoma
9	2.4	F	2.0	38×30	320×180×80	5.5	LMA	End-stage renal disease
10	0.5	M	1.8	26×21	320×180×80	9.3	NC	Liver transplant
11	1.7	M	2.0	28×22	320×180×80	9.2	ETT	Rhabdoid tumor
12	3.3	M	2.4	32×26	320×180×68	7.7	LMA	Abdominal mass
13	2.8	M	2.4	32×24	320×168×64	7.4	NC	Wilms tumor
14	1.0	F	2.0	30×24	320×180×74	8.3	LMA	Neuroblastoma
15	2.6	F	2.4	30×24	320×180×68	8.1	ETT	Hepatoblastoma
16	0.0	M	1.0	26×26	320×192×110	13.5	ETT	Neuroblastoma
17	6.9	M	2.4	32×24	320×168×72	7.9	NC	Neuroblastoma
18	2.2	F	1.4	32×26	320×180×120	14.1	ETT	Langerhans cell histiocytosis
19	8.4	F	2.4	34×27	320×180×60	6.7	None	Medulloblastoma
20	7.3	F	2.0	32×26	320×180×80	8.8	NC	Wilms tumor
21	4.2	F	2.4	32×26	320×180×70	8.3	LMA	Wilms tumor
22	2.7	M	2.0	30×24	320×180×80	9.2	LMA	Mature teratoma
23	7.1	M	2.0	38×30	320×180×80	8.1	NC	Rhabdomyosarcoma
24	3.2	M	2.4	34×26	320×168×82	9.4	ETT	Pancreaticoblastoma
25	7.2	M	2.4	34×27	320×180×76	8.9	NC	Neuroblastoma
26	1.9	F	2.4	30×24	320×180×66	7.9	NC	Sacrococcygeal teratoma
27	4.0	M	2.4	38×30	320×180×80	8.6	NC	Sickle cell disease

^*ETT endotracheal tube, F female, FOV field of view, LMA laryngeal mask, M male, NC nasal cannula